COMPANYGALD (SIX)

Galderma

Galderma is a global dermatology company spanning therapeutics, aesthetics and skincare.

Analyst Perspective

Galderma Group AG is a publicly listed pure-play dermatology company headquartered in Switzerland. It develops and sells prescription therapeutics, injectable aesthetic treatments and dermatological skincare products. The company operates globally and reported FY2025 net sales of USD 5.207 billion, indicating large-scale commercial execution across medical and consumer skin-health segments. Galderma generates revenue by selling branded dermatology products through healthcare, aesthetics and skincare channels. Its customers include dermatologists, aesthetic physicians and clinics, pharmacies, distributors, retailers and end-consumers purchasing skincare products. The business model combines medical-product sales with aesthetics and skincare demand, giving it exposure to both clinician-driven and consumer-led spending.

Analyst Signal Briefing

Updated: 30 Jul 2026

No strategic news signals detected in the last 90 days.

Explorer Tier

Start exploring for free

Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.

Free
  • View public Company Profiles
  • Save/watch companies
  • Build your first Watchlist
  • Access additional market signals

Category Differentiation

Galderma is a dermatology products company, not an adtech, martech or software platform. It operates as a skin-health manufacturer and brand spanning therapeutics, aesthetics and skincare.

Galderma: About

Galderma creates value by researching, developing, manufacturing and commercialising dermatology-focused products across prescription therapeutics, injectable aesthetics and skincare. It monetises this portfolio through product sales into professional healthcare channels and consumer skincare channels, using brand equity, clinical positioning and global distribution to drive repeat demand.

How Galderma Works & Monetises

Business model analysis and core revenue streams

Galderma primarily monetises through product sales. Revenue comes from prescription therapeutics sold via medical channels, injectable aesthetic treatments sold to clinics and physicians, and dermatological skincare sold through retail, pharmacy and professional channels. The commercial model is based on recurring replenishment and repeat purchase rather than subscriptions or advertising.

Revenue Channels

Dermatological product salesOne-time Sale
Injectable aesthetic treatment salesOne-time Sale
Dermatological skincare salesOne-time Sale

Side-by-Side Comparisons

Compare Galderma directly with top competitors

Galderma: Key Competitors & Alternatives

View full competitor landscape

Recent Signals (Galderma)

DigidayMar 30, 2026

AI Tools Transform Influencer Creator Selection

Agencies are increasingly using AI-driven discovery and selection tools to scale and optimize influencer campaigns. Dentsu has deployed an AI agent called Creator & Trends Studio (CATS) — built around an API deal with Meta — to recommend creators by topic, profile and trend participation. Independent agencies such as Later use AI to match briefs with candidate creators and model expected content performance from historical engagement. Brands and agencies say the tools enable managing far larger creator rosters (Walmart cited “hundreds of thousands” of creators) and improve measurable outcomes; Dentsu reported uplifts for clients including Elizabeth Arden (14.3% increase in unaided ad recall and 41% rise in sales conversions from partnership ads). Agencies emphasize human oversight remains for top-tier talent, while AI handles large-scale discovery for nano- and micro-influencer programs.

Read original source
AdExchangerDec 1, 2025

Differin's Gaming Campaign Boosts Acne Awareness Among Gen Z

Galderma's Differin acne-treatment brand aimed to connect with Gen Z gamers by weaving marketing into the gaming ecosystem. After partnering with Fortnite streamers Chica and NickEh30 on Twitch, Differin allowed creators to share personal acne stories, subtly link to product purchases, and track impact on sales. The result: purchase intent rose 7,000% and awareness increased 46%, with Google search interest up 82% and earned media growth as fans talked about the brand online. Buoyed by this success, Differin expanded into Roblox with a Level Up Lobby experience featuring acne-education mini-games. Titles include a Temple Run-inspired obstacle run to dodge hormones, Power Patch Splat (Dance Dance Revolution-style), and Zit Zapper. Players could upload purchase receipts to earn in-game power-ups, with over 200,000 participants and 3 million visits. The campaign, advised by Dentsu's Val Vacante, was designed to be authentic, measurable, and to connect with a trusted Gen Z audience.

Read original source
AdExchangerJul 22, 2025

Ad Tech Evolves: ChatGPT, Tariffs, and Influencer Marketing

Ad Exchanger’s Tuesday digest highlights how data-driven ad tech is adapting to tariffs, AI-driven search shifts, and influencer marketing. It notes YKK’s creation of a global marketing team to connect events, trends, and supply-chain dynamics to regional earnings, a move prompted by tariff pressures. The piece also shows Gen Z increasingly turning to ChatGPT for product recommendations, with Cetaphil reporting 40–50% of this cohort consulting ChatGPT in stores and adjusting online descriptions to align with likely queries, supported by a push to cite clinical journals and influencer content. Vacation, a pandemic-born sunscreen brand, is leveraging influencer programs and securing end-aisle shelf space at Target, while Numerator lists it at 13th in sunscreen with 1.1% share. Finally, the roundup notes OpenAI and Nvidia partnering with brands such as Yum Brands and Mattel, alongside other industry shifts.

Read original source

Galderma: Frequently Asked Questions

What is Galderma?

Galderma is a publicly listed pure-play dermatology company that develops and sells prescription therapeutics, injectable aesthetic treatments and dermatological skincare products.

Who uses Galderma?

Galderma serves dermatologists, aesthetic physicians, clinics, pharmacies, retailers, distributors and consumers who buy skincare products.

How does Galderma make money?

Galderma makes money by selling dermatology products across therapeutic, injectable aesthetics and skincare categories through medical and consumer channels.

Company Facts

Founded
1981
Headquarters
Zählerweg 10, 6300 Zug, Switzerland
Core Segment
Advertiser / Brand
Company Size
>5,000
Official Link
galderma.com